209 related articles for article (PubMed ID: 25510269)
1. The role of mutations in epigenetic regulators in myeloid malignancies.
Woods BA; Levine RL
Immunol Rev; 2015 Jan; 263(1):22-35. PubMed ID: 25510269
[TBL] [Abstract][Full Text] [Related]
2. [Mutations of epigenetic regulator genes and myeloid malignancies].
Muto T; Sashida G; Oshima M; Iwama A
Rinsho Ketsueki; 2015 Nov; 56(11):2287-94. PubMed ID: 26666714
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors.
Ungerstedt JS
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304859
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia: therapeutic impact of epigenetic drugs.
Altucci L; Clarke N; Nebbioso A; Scognamiglio A; Gronemeyer H
Int J Biochem Cell Biol; 2005 Sep; 37(9):1752-62. PubMed ID: 15964234
[TBL] [Abstract][Full Text] [Related]
5. The role of mutations in epigenetic regulators in myeloid malignancies.
Shih AH; Abdel-Wahab O; Patel JP; Levine RL
Nat Rev Cancer; 2012 Sep; 12(9):599-612. PubMed ID: 22898539
[TBL] [Abstract][Full Text] [Related]
6. [Research on molecular markers for epigenetic changes in myeloid malignancies].
Li L; Sun XM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):687-92. PubMed ID: 24327148
[TBL] [Abstract][Full Text] [Related]
7. Mutational determinants of epigenetic instablity in myeloid malignancies.
Jankowska AM; Szpurka H
Semin Oncol; 2012 Feb; 39(1):80-96. PubMed ID: 22289495
[TBL] [Abstract][Full Text] [Related]
8. [Myeloid neoplasms in the World Health Organization 2016 classification].
Asou N
Rinsho Ketsueki; 2017; 58(10):2178-2187. PubMed ID: 28978863
[TBL] [Abstract][Full Text] [Related]
9. Cytosine modifications in myeloid malignancies.
Meldi KM; Figueroa ME
Pharmacol Ther; 2015 Aug; 152():42-53. PubMed ID: 25956466
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic deregulation in myeloid malignancies.
Meldi KM; Figueroa ME
Transl Res; 2015 Jan; 165(1):102-14. PubMed ID: 24813528
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming.
Zardo G; Cimino G; Nervi C
Leukemia; 2008 Aug; 22(8):1503-18. PubMed ID: 18548105
[TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferases in hematologic malignancies.
Li KK; Luo LF; Shen Y; Xu J; Chen Z; Chen SJ
Semin Hematol; 2013 Jan; 50(1):48-60. PubMed ID: 23507483
[TBL] [Abstract][Full Text] [Related]
13. Chromatin modifiers and the promise of epigenetic therapy in acute leukemia.
Greenblatt SM; Nimer SD
Leukemia; 2014 Jul; 28(7):1396-406. PubMed ID: 24609046
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.
Feinberg AP; Koldobskiy MA; Göndör A
Nat Rev Genet; 2016 May; 17(5):284-99. PubMed ID: 26972587
[TBL] [Abstract][Full Text] [Related]
15. The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications.
Malcovati L; Ambaglio I; Elena C
Curr Opin Oncol; 2015 Nov; 27(6):551-9. PubMed ID: 26352542
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic and clinical impact of genetics and epigenetics in acute myeloid leukemia.
Ohgami RS; Arber DA
Int J Lab Hematol; 2015 May; 37 Suppl 1():122-32. PubMed ID: 25976970
[TBL] [Abstract][Full Text] [Related]
17. The biology and clinical impact of genetic lesions in myeloid malignancies.
Lindsley RC; Ebert BL
Blood; 2013 Nov; 122(23):3741-8. PubMed ID: 23954890
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic heterogeneity in acute myeloid leukemia.
Li S; Mason CE; Melnick A
Curr Opin Genet Dev; 2016 Feb; 36():100-6. PubMed ID: 27162099
[TBL] [Abstract][Full Text] [Related]
19. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulators and their impact on therapy in acute myeloid leukemia.
Pastore F; Levine RL
Haematologica; 2016 Mar; 101(3):269-78. PubMed ID: 26928248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
